@prefix this: . @prefix sub: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-gda: . @prefix dgn-void: . sub:head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:publicationInfo; a np:Nanopublication . } sub:assertion { dgn-gda:DGNf429e25419c2dfad1b0ca1859475c026 sio:SIO_000628 miriam-gene:2475, lld:C0020541; a sio:SIO_001120 . } sub:provenance { sub:assertion dcterms:description "[The AKT/mTOR signaling pathway was markedly activated in the early phase of cirrhotic portal hypertension induced by BDL in rats. mTOR blockade by rapamycin profoundly improved liver function by limiting inflammation, fibrosis and portal pressure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_predicted; sio:SIO_000772 miriam-pubmed:24404143; prov:wasDerivedFrom dgn-void:RGD; prov:wasGeneratedBy eco:ECO_0000218 . dgn-void:RGD pav:importedOn "2017-01-25"^^xsd:date . dgn-void:source_evidence_predicted a eco:ECO_0000266; rdfs:comment "Gene-disease associations inferred from animal model manually asserted gene-disease associations."@en; rdfs:label "DisGeNET evidence - PREDICTED"@en . } sub:publicationInfo { this: dcterms:created "2017-10-17T13:12:50+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v5.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v5.0.0" . }